Bioline Rx reported $2.63M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Arca Biopharma USD 25.09M 5.23M Mar/2025
Bio Path USD 3.24M 616K Mar/2025
Bioline Rx USD 2.63M 24K Sep/2025
Capricor Therapeutics USD 24.98M 6.15M Mar/2025